Varex Imaging Corporation

Varex Imaging Corporation

VREXยทNASDAQ

$10.48

+5.4%
HealthcareMedical - Devices

Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys. This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications. Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was founded in 2016 and is based in Salt Lake City, Utah.

At a Glance

Live Snapshot
Market Cap$441.21M
EPS-1.7000
P/E Ratio-6.16
Earnings Date08/06/2026
Varex Imaging Corporation

Varex Imaging Corporation Fair Value Envelope

VREX ยท NASDAQ

Our analysis suggests that VREX has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $10.48, this represents a potential HIDDEN relative to our calculated worth for Varex Imaging Corporation.

Intrinsic Value
Current Price: $10.48

Owner Earnings Valuation Tool

Warren Buffett's Owner Earnings DCF analysis for intrinsic value calculation

Historical Financial Data

Base year metrics used for projections

$
%
$
%
$
$

Projection Settings

Forecast period and terminal assumptions

%
%

DCF Valuation Summary

Calculation flow from present value to intrinsic value per share

Present Value$300.9M
+ Cash & Equivalents$145.0M
Firm Value$445.9M
- Debt$401.9M
Equity Value$44.0M
/ Shares Outstanding41,501,223B
DCF Value$1
OVERVALUED BY 90%

Owner Earnings Projections

Operating Cash Flow - Maintenance CapEx = Owner Earnings

Metric
Year 1
Year 2
Year 3
Year 4
Year 5
Year 6
Year 7
Year 8
Year 9
Year 10
Operating Cash Flow
$38.4M
$35.4M
$32.6M
$30.1M
$27.7M
$25.5M
$23.5M
$21.7M
$20.0M
$18.4M
Maintenance CapEx
-$4.2M
-$3.9M
-$3.6M
-$3.3M
-$3.0M
-$2.8M
-$2.6M
-$2.4M
-$2.2M
-$2.0M
Owner Earnings
$34.2M
$31.5M
$29.1M
$26.8M
$24.7M
$22.7M
$21.0M
$19.3M
$17.8M
$16.4M
Discount Factor
0.926
0.857
0.794
0.735
0.681
0.630
0.583
0.540
0.500
0.463
Present Value
$31.7M
$27.0M
$23.1M
$19.7M
$16.8M
$14.3M
$12.2M
$10.4M
$8.9M
$7.6M
Terminal Value represents 42.9% of Enterprise Value